Evogene Ltd. (EVGN) stock
EVGNNasdaqAgricultural ChemicalsFiscal year ends December 31
$0.39+0.02 (+5.58%)
Close on Nov 16, 2026Market cap $3.41MP/E 0.4Yield –
Evogene operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -$13.50M. The highest annual figure on record is -$11.69M in fiscal 2016.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$13.50M | – |
| FY2024 | Dec 31, 2024 | -$19.70M | – |
| FY2023 | Dec 31, 2023 | -$21.58M | – |
| FY2022 | Dec 31, 2022 | -$23.68M | – |
| FY2021 | Dec 31, 2021 | -$24.72M | – |
| FY2020 | Dec 31, 2020 | -$19.51M | – |
| FY2019 | Dec 31, 2019 | -$17.67M | – |
| FY2018 | Dec 31, 2018 | -$15.16M | – |
| FY2017 | Dec 31, 2017 | -$15.93M | – |
| FY2016 | Dec 31, 2016 | -$11.69M | – |
| FY2015 | Dec 31, 2015 | -$12.41M | – |
See a number that looks wrong?